Difference between revisions of "Bicalutamide (Casodex)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>")
(updated content)
Line 1: Line 1:
 +
Also known as Cosudex, Calutide, or Kalumid.
 +
 
==General information==
 
==General information==
Class/mechanism: Antiandrogen; non-steroidal androgen receptor inhibitor that competitively inhibits androgens by binding to cytosol androgen receptors.<ref name="insert">[http://www1.astrazeneca-us.com/pi/casodex.pdf Bicalutamide (Casodex) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/bicalutamide.pdf Bicalutamide (Casodex) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Antiandrogen; non-steroidal androgen receptor inhibitor that competitively inhibits androgens by binding to cytosol androgen receptors.<ref name="insert">[http://www1.astrazeneca-us.com/pi/casodex.pdf Bicalutamide (Casodex) package insert]</ref><ref>[[Media:Bicalutamide.pdf | Bicalutamide (Casodex) package insert (locally hosted backup)]]</ref>
 
<br>Route: PO
 
<br>Route: PO
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>  
 +
 +
==Diseases for which it is used==
 +
*[[Prostate cancer]]
  
 
==Patient drug information==
 
==Patient drug information==
*[http://chemocare.com/bio/bicalutamide.asp Bicalutamide (Casodex) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/bicalutamide.asp Bicalutamide (Casodex) patient drug information (Chemocare)]</ref>
+
*[http://www1.astrazeneca-us.com/pi/casodex.pdf#page=20 Bicalutamide (Casodex) package insert pages 20-24]<ref name="insert"></ref>
 +
*[http://chemocare.com/chemotherapy/drug-info/bicalutamide.aspx Bicalutamide (Casodex) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/bicalutamide.aspx Bicalutamide (Casodex) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/bicalutamide-patient-drug-information Bicalutamide (Casodex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/bicalutamide-patient-drug-information Bicalutamide (Casodex) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/bicalutamide-patient-drug-information Bicalutamide (Casodex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/bicalutamide-patient-drug-information Bicalutamide (Casodex) patient drug information (UpToDate)]</ref>
  
 
==References==
 
==References==
 
<references/>
 
<references/>

Revision as of 19:35, 7 October 2012

Also known as Cosudex, Calutide, or Kalumid.

General information

Class/mechanism: Antiandrogen; non-steroidal androgen receptor inhibitor that competitively inhibits androgens by binding to cytosol androgen receptors.[1][2]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

References